Sensipar Side Effects

Generic name: cinacalcet

Note: This document contains side effect information about cinacalcet. Some of the dosage forms listed on this page may not apply to the brand name Sensipar.

Some side effects of Sensipar may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

For the Consumer

Applies to cinacalcet: oral tablet

Get emergency medical help if you have any of these signs of an allergic reaction while taking cinacalcet (the active ingredient contained in Sensipar) hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have a serious side effect such as:

  • numbness or tingly feeling around your mouth, fast or slow heart rate, muscle tightness or contraction, overactive reflexes;

  • seizure (convulsions);

  • feeling short of breath, even with mild exertion;

  • swelling, rapid weight gain; or

  • feeling like you might pass out.

Less serious side effects of cinacalcet may include:

  • nausea, vomiting, diarrhea;

  • loss of appetite;

  • muscle pain, mild chest pain;

  • dizziness; or

  • weakness;

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For Healthcare Professionals

Applies to cinacalcet: oral tablet

Cardiovascular

Common (1% to 10%): Hypertension (7%)
Postmarketing reports: Isolated, idiosyncratic cases of hypotension, worsening heart failure, and/or arrhythmia

Gastrointestinal

Very common (10% or more): Nausea (19 to 31%), vomiting (15 to 27%), diarrhea (20 to 21%)
Common (1% to 10%): Anorexia (6 to 7%), constipation (3 to 6%)

Musculoskeletal

Very common (10% or more): Myalgia (15%)
Common (1% to 10%): Fracture (6 to 8%), arthralgia (6%), noncardiac chest pain (6%), limb pain (5%)

Nervous system

Very common (10% or more):
Common (1% to 10%): Fatigue (8%), dizziness (7%), depression (6%), headache (6%), asthenia (6%)

Hypersensitivity

Postmarketing reports: Rash, angioedema, urticaria

Local

Common (1% to 10%): Access site infection (5%)

Dermatologic

Very common (10% or more): Paresthesia (14 to 29%)
Frequency not reported: One report of leukocytoclastic vasculitis with palpable purpura on both upper and lower extremities

Hematologic

Common (1% to 10%): Anemia (7%)

Metabolic

Common (1% to 10%): Dehydration (7%)

Respiratory

Very common (10% or more): Upper respiratory infection (11%)

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Advertisement
Close

Recommended

(web3)